Ogilvie, Gina S

Published purpose

The Eliminating Cervical Cancer in Canada funding opportunity is expected to: • Maintain and/or strengthen a high quality research program for implementation science, clinical, health services, and population health research to achieve better clinical, economic, and population health outcomes related to the elimination of cervical cancer for the benefit of Canadians; • Examine the effectiveness of HPV vaccine schedules, including 1 dose schedules; • Evaluate the requirement for booster doses for the HPV vaccine for males and females; • Improve understanding of, access to, and uptake of cervical cancer screening among underserved populations with appropriate consideration of income, cultural background, geographic location, education, gender, and other intersecting factors; • Improve understanding of, access to, and uptake of HPV vaccination among the general population, including consideration of the role of parents and guardians, as well as appropriate consideration of how income, cultural background, geographic location, education, gender, and other intersecting factors may be contributing to vaccine hesitancy; • Assess the feasibility, suitability and implementation of HPV self-collection for underscreened populations with appropriate consideration of how income, cultural background, geographic location, education, gender, and other intersecting factors may affect effective implementation; and • Establish a network of collaborative centres to ensure that good practices and learnings from the grant recipients are translated nationally to maximize the impact and outcomes of the research program across jurisdictions for the benefit of Canadians.